Page last updated: 2024-08-25

rosiglitazone and Intraepithelial Prostatic Neoplasia

rosiglitazone has been researched along with Intraepithelial Prostatic Neoplasia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boone, B; Cai, H; Fernandez, S; Hayward, SW; He, Y; Jerome, WG; Jiang, M; Magnuson, MA; Matusik, RJ; Roy-Burman, P; Shappell, SB; Yi, Y; Yu, X1

Other Studies

1 other study(ies) available for rosiglitazone and Intraepithelial Prostatic Neoplasia

ArticleYear
Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.
    Cell death and differentiation, 2010, Volume: 17, Issue:3

    Topics: Animals; Autophagy; Cell Line; Epithelial Cells; Gene Expression Profiling; Hypoglycemic Agents; Male; Mice; Mice, SCID; Mice, Transgenic; Molecular Sequence Data; Phenotype; PPAR gamma; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Protein Isoforms; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transplantation, Heterologous

2010